ArticleScientific reports2016

Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis.

Hao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.